Ectodomain shedding by ADAM17: Its ole in neutrophil recruitment and the Impairment of this process during sepsis

Frontiers in Cellular and Infection Microbiology

Volumn 7, Issue APR, 2017, Pages

  Mishra, Hemant K ^a   Ma, Jing ^a   Walcheck, Bruce ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Adhesion; Bacteria; Infection; Inflammation; Leukocyte

Indexed keywords

ADAM10 ENDOPEPTIDASE; CELL ADHESION MOLECULE; MATRIX METALLOPROTEINASE; MEMBRANE PROTEIN; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;

ADHESION; ARTICLE; BACTERIAL CLEARANCE; CELL ACTIVATION; DOWN REGULATION; LEUKOCYTE MIGRATION; NEUTROPHIL; NONHUMAN; SEPSIS; VASCULAR ENDOTHELIUM; ANIMAL; BACTERIUM; BLOOD; CELL ADHESION; CELL MOTION; DISEASE MODEL; DRUG EFFECTS; ENDOTHELIUM CELL; HUMAN; IMMUNOLOGY; INFLAMMATION; METABOLISM; NEUTROPHIL CHEMOTAXIS; PATHOGENICITY; PHYSIOLOGY;

ADAM17 PROTEIN; ANIMALS; BACTERIA; CELL ADHESION; CELL MOVEMENT; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; NEUTROPHIL INFILTRATION; NEUTROPHILS; SEPSIS;

EID: 85020895671     PISSN: None     EISSN: 22352988     Source Type: Journal    
DOI: 10.3389/fcimb.2017.00138     Document Type: Article

References (128)

1. Adrain, C., Zettl, M., Christova, Y., Taylor, N., and Freeman, M. (2012). Tumor necrosis factor signaling requires iRhom2 to promote trafficking and activation of TACE. Science 335, 225–228. doi: 10.1126/science.1214400
2. Alexander, S. R., Kishimoto, T. K., and Walcheck, B. (2000). Effects of selective protein kinase C inhibitors on the proteolytic down-regulation of L-selectin from chemoattractant-activated neutrophils. J. Leukoc. Biol. 67, 415–422.
3. Alves-Filho, J. C., Freitas, A., Souto, F. O., Spiller, F., Paula-Neto, H., Silva, J. S., et al. (2009). Regulation of chemokine receptor by Toll-like receptor 2 is critical to neutrophil migration and resistance to polymicrobial sepsis. Proc. Natl. Acad. Sci. U.S.A. 106, 4018–4023. doi: 10.1073/pnas.0900196106
4. Alves-Filho, J. C., Sônego, F., Souto, F. O., Freitas, A., Verri, W. A. Jr., Auxiliadora-Martins, M., et al. (2010a). Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection. Nat. Med. 16, 708–712. doi: 10.1038/nm.2156
5. Alves-Filho, J. C., Spiller, F., and Cunha, F. Q. (2010b). Neutrophil paralysis in sepsis. Shock 34(Suppl. 1), 15–21. doi: 10.1097/SHK.0b013e3181e7e61b
6. Amour, A., Slocombe, P. M., Webster, A., Butler, M., Knight, C. G., Smith, B. J., et al. (1998). TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3. FEBS Lett. 435, 39–44. doi: 10.1016/S0014-5793(98)01031-X
7. Arndt, P. G., Strahan, B., Wang, Y., Long, C., Horiuchi, K., and Walcheck, B. (2011). Leukocyte ADAM17 regulates acute pulmonary inflammation. PLoS ONE 6:e19938. doi: 10.1371/journal.pone.0019938
8. Bargatze, R. F., Kurk, S., Butcher, E. C., and Jutila, M. A. (1994). Neutrophils roll on adherent neutrophils bound to cytokine-induced endothelial cells via L-selectin on the rolling cells. J. Exp. Med. 180, 1785–1792. doi: 10.1084/jem.180. 5.1785
9. Bell, J. H., Herrera, A. H., Li, Y., and Walcheck, B. (2007). Role of ADAM17 in the ectodomain shedding of TNF-alpha and its receptors by neutrophils and macrophages. J. Leukoc. Biol. 82, 173–176. doi: 10.1189/jlb. 0307193
10. Bennett, T.A., Edwards, B.S., Sklar, L.A., and Rogelj, S. (2000). Sulfhydryl regulation of L-selectin shedding: phenylarsine oxide promotes activationindependent L-selectin shedding from leukocytes. J. Immunol. 164, 4120–4129. doi: 10.4049/jimmunol.164.8.4120
11. Bergmeier, W., Piffath, C. L., Cheng, G., Dole, V. S., Zhang, Y., Von Andrian, U. H., et al. (2004). Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates GPIbalpha shedding from platelets in vitro and in vivo. Circ. Res. 95, 677–683. doi: 10.1161/01.RES.0000143899.73453.11
12. Black, R. A., Rauch, C. T., Kozlosky, C. J., Peschon, J. J., Slack, J. L., Wolfson, M. F., et al. (1997). A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 385, 729–733. doi: 10.1038/385729a0
13. Blaydon, D. C., Biancheri, P., Di, W. L., Plagnol, V., Cabral, R. M., Brooke, M. A., et al. (2011). Inflammatory skin and bowel disease linked to ADAM17 deletion. N. Engl. J. Med. 365, 1502–1508. doi: 10.1056/NEJMoa1100721
14. Brandl, K., Sun, L., Neppl, C., Siggs, O. M., Le Gall, S. M., Tomisato, W., et al. (2010). MyD88 signaling in nonhematopoietic cells protects mice against induced colitis by regulating specific EGF receptor ligands. Proc. Natl. Acad. Sci. U.S.A. 107, 19967–19972. doi: 10.1073/pnas.1014669107
15. Brill, A., Chauhan, A. K., Canault, M., Walsh, M. T., Bergmeier, W., and Wagner, D. D. (2009). Oxidative stress activates ADAM17/TACE and induces its target receptor shedding in platelets in a p38-dependent fashion. Cardiovasc. Res. 84, 137–144. doi: 10.1093/cvr/cvp176
16. Brown, K.A., Brain, S.D., Pearson, J.D., Edgeworth, J.D., Lewis, S.M., and Treacher, D.F. (2006). Neutrophils in development of multiple organ failure in sepsis. Lancet 368, 157–169. doi: 10.1016/S0140-6736(06)69005-3
17. Cacalano, G., Lee, J., Kikly, K., Ryan, A. M., Pitts-Meek, S., Hultgren, B., et al. (1994). Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog. Science 265, 682–684. doi: 10.1126/science.8036519
18. Caescu, C. I., Jeschke, G. R., and Turk, B. E. (2009). Active-site determinants of substrate recognition by the metalloproteinases TACE and ADAM10. Biochem. J. 424, 79–88. doi: 10.1042/BJ20090549
19. Chalaris, A., Adam, N., Sina, C., Rosenstiel, P., Lehmann-Koch, J., Schirmacher, P., et al. (2010). Critical role of the disintegrin metalloprotease ADAM17 for intestinal inflammation and regeneration in mice. J. Exp. Med. 207, 1617–1624. doi: 10.1084/jem.20092366
20. Chalaris, A., Rabe, B., Paliga, K., Lange, H., Laskay, T., Fielding, C. A., et al. (2007). Apoptosis is a natural stimulus of IL6R shedding and contributes to the proinflammatory trans-signaling function of neutrophils. Blood 110, 1748–1755. doi: 10.1182/blood-2007-01-067918
21. Christova, Y., Adrain, C., Bambrough, P., Ibrahim, A., and Freeman, M. (2013). Mammalian iRhoms have distinct physiological functions including an essential role in TACE regulation. EMBO Rep. 14, 884–890. doi: 10.1038/embor.2013.128
22. Cohen, J., Vincent, J. L., Adhikari, N. K. J., Machado, F. R., Angus, D. C., Calandra, T., et al. (2015). Sepsis: a roadmap for future research. Lancet Infect. Dis. 15, 581–614. doi: 10.1016/S1473-3099(15)70112-X
23. Cowley, H. C., Heney, D., Gearing, A. J., Hemingway, I., and Webster, N. R. (1994). Increased circulating adhesion molecule concentrations in patients with the systemic inflammatory response syndrome: a prospective cohort study. Crit. Care Med. 22, 651–657. doi: 10.1097/00003246-199404000-00022
24. Dellinger, R. P., and Vincent, J. L. (2005). The surviving sepsis campaign sepsis change bundles and clinical practice. Crit. Care 9, 653–654. doi: 10.1186/cc3952
25. Díaz-Rodríguez, E., Montero, J. C., Esparís-Ogando, A., Yuste, L., and Pandiella, A. (2002). Extracellular signal-regulated kinase phosphorylates tumor necrosis factor alpha-converting enzyme at threonine 735: a potential role in regulated shedding. Mol. Biol. Cell 13, 2031–2044. doi: 10.1091/mbc.01-11-0561
26. Doedens, J. R., and Black, R. A. (2000). Stimulation-induced down-regulation of tumor necrosis factor-alpha converting enzyme. J. Biol. Chem. 275, 14598–14607. doi: 10.1074/jbc.275.19.14598
27. Doedens, J. R., Mahimkar, R. M., and Black, R. A. (2003). TACE/ADAM-17 enzymatic activity is increased in response to cellular stimulation. Biochem. Biophys. Res. Commun. 308, 331–338. doi: 10.1016/S0006-291X(03)01381-0
28. Doroshenko, T., Chaly, Y., Savitskiy, V., Maslakova, O., Portyanko, A., Gorudko, I., et al. (2002). Phagocytosing neutrophils down-regulate the expression of chemokine receptors CXCR1 and CXCR2. Blood 100, 2668–2671. doi: 10.1182/blood.100.7.2668
29. Dreymueller, D., Martin, C., Kogel, T., Pruessmeyer, J., Hess, F. M., Horiuchi, K., et al. (2012). Lung endothelial ADAM17 regulates the acute inflammatory response to lipopolysaccharide. EMBO Mol. Med. 4, 412–423. doi: 10.1002/emmm.201200217
30. Duffy, M. J., Mullooly, M., O'donovan, N., Sukor, S., Crown, J., Pierce, A., et al. (2011). The ADAMs family of proteases: new biomarkers and therapeutic targets for cancer? Clin. Proteomics 8:9. doi: 10.1186/1559-0275-8-9
31. Düsterhöft, S., Jung, S., Hung, C. W., Tholey, A., Sonnichsen, F. D., Grötzinger, J., et al. (2013). Membrane-proximal domain of a disintegrin and metalloprotease-17 represents the putative molecular switch of its shedding activity operated by protein-disulfide isomerase. J. Am. Chem. Soc. 135, 5776–5781. doi: 10.1021/ja400340u
32. Edwards, D. R., Handsley, M. M., and Pennington, C. J. (2008). The ADAM metalloproteinases. Mol. Aspects Med. 29, 258–289. doi: 10.1016/j.mam.2008.08.001
33. Ertel, W., Scholl, F. A., Gallati, H., Bonaccio, M., Schildberg, F. W., and Trentz, O. (1994). Increased release of soluble tumor necrosis factor receptors into blood during clinical sepsis. Arch. Surg. 129, 1330–1336; discussion 1336–1337. doi: 10.1001/archsurg.1994.01420360120017
34. Fan, H., and Derynck, R. (1999). Ectodomain shedding of TGF-alpha and other transmembrane proteins is induced by receptor tyrosine kinase activation and MAP kinase signaling cascades. EMBO J. 18, 6962–6972. doi: 10.1093/emboj/18.24.6962
35. Friedman, S., Levy, R., Garrett, W., Doval, D., Bondarde, S., Sahoo, T., et al. (2009). Clinical benefit of INCB7839, a potent and selective inhibitor of ADAM10 and ADAM17, in combination with trastuzumab in metastatic HER2 positive breast cancer patients. Cancer Res. 69:5056. doi: 10.1158/0008-5472.SABCS-09-5056
36. Galon, J., Moldovan, I., Galinha, A., Provost-Marloie, M. A., Kaudewitz, H., Roman-Roman, S., et al. (1998). Identification of the cleavage site involved in production of plasma soluble Fc gamma receptor type III (CD16). Eur. J. Immunol. 28, 2101–2107. doi: 10.1002/(SICI)1521-4141(199807)28:07<2101::AID-IMMU2101>3.0.CO;2-W 3.0.CO;2-W
37. Garton, K. J., Gough, P. J., Philalay, J., Wille, P. T., Blobel, C. P., Whitehead, R. H., et al. (2003). Stimulated shedding of vascular cell adhesion molecule 1 (VCAM-1) is mediated by tumor necrosis factor-alpha-converting enzyme (ADAM 17). J. Biol. Chem. 278, 37459–37464. doi: 10.1074/jbc.M305877200
38. Gearing, A. J., and Newman, W. (1993). Circulating adhesion molecules in disease. Immunol. Today 14, 506–512. doi: 10.1016/0167-5699(93)90267-O
39. Gechtman, Z., Alonso, J. L., Raab, G., Ingber, D. E., and Klagsbrun, M. (1999). The shedding of membrane-anchored heparin-binding epidermallike growth factor is regulated by the Raf/mitogen-activated protein kinase cascade and by cell adhesion and spreading. J. Biol. Chem. 274, 28828–28835. doi: 10.1074/jbc.274.40.28828
40. Goncalves, A. S., and Appelberg, R. (2002). The involvement of the chemokine receptor CXCR2 in neutrophil recruitment in LPS-induced inflammation and in Mycobacterium avium infection. Scand. J. Immunol. 55, 585–591. doi: 10.1046/j.1365-3083.2002.01097.x
41. Gonzales, P. E., Solomon, A., Miller, A. B., Leesnitzer, M. A., Sagi, I., and Milla, M. E. (2004). Inhibition of the tumor necrosis factor-alpha-converting enzyme by its pro domain. J. Biol. Chem. 279, 31638–31645. doi: 10.1074/jbc.M401311200
42. Gooz, M. (2010). ADAM-17: the enzyme that does it all. Crit. Rev. Biochem. Mol. Biol. 45, 146–169. doi: 10.3109/10409231003628015
43. Gotts, J. E., and Matthay, M. A. (2016). Sepsis: pathophysiology and clinical management. BMJ 353 i1585. doi: 10.1136/bmj.i1585
44. Hartmann, M., Herrlich, A., and Herrlich, P. (2013). Who decides when to cleave an ectodomain? Trends Biochem. Sci. 38, 111–120. doi: 10.1016/j.tibs.2012.12.002
45. Hassemer, E. L., Le Gall, S. M., Liegel, R., Mcnally, M., Chang, B., Zeiss, C. J., et al. (2010). The waved with open eyelids (woe) locus is a hypomorphic mouse mutation in Adam17. Genetics 185, 245–255. doi: 10.1534/genetics.109.113167
46. Horiuchi, K., Kimura, T., Miyamoto, T., Takaishi, H., Okada, Y., Toyama, Y., et al. (2007a). Cutting edge: TNF-alpha-converting enzyme (TACE/ADAM17) inactivation in mouse myeloid cells prevents lethality from endotoxin shock. J. Immunol. 179, 2686–2689. doi: 10.4049/jimmunol.179.5.2686
47. Horiuchi, K., Le Gall, S., Schulte, M., Yamaguchi, T., Reiss, K., Murphy, G., et al. (2007b). Substrate selectivity of epidermal growth factor-receptor ligand sheddases and their regulation by phorbol esters and calcium influx. Mol. Biol. Cell 18, 176–188. doi: 10.1091/mbc.E06-01-0014
48. Issuree, P. D., Maretzky, T., Mcilwain, D. R., Monette, S., Qing, X., Lang, P. A., et al. (2013). iRHOM2 is a critical pathogenic mediator of inflammatory arthritis. J. Clin. Invest. 123, 928–932. doi: 10.1172/jci66168
49. Jing, Y., Ni, Z., Wu, J., Higgins, L., Markowski, T. W., Kaufman, D. S., et al. (2015). Identification of an ADAM17 cleavage region in human CD16 (FcgammaRIII) and the engineering of a non-cleavable version of the receptor in NK cells. PLoS ONE 10:e0121788. doi: 10.1371/journal.pone.0121788
50. Jones, J. C., Rustagi, S., and Dempsey, P. J. (2016). ADAM Proteases and gastrointestinal function. Annu. Rev. Physiol. 78, 243–276. doi: 10.1146/annurev-physiol-021014-071720
51. Kermarrec, N., Selloum, S., Plantefeve, G., Chosidow, D., Paoletti, X., Lopez, A., et al. (2005). Regulation of peritoneal and systemic neutrophil-derived tumor necrosis factor-alpha release in patients with severe peritonitis: role of tumor necrosis factor-alpha converting enzyme cleavage. Crit. Care Med. 33, 1359–1364. doi: 10.1097/01.CCM.0000166359.47577.57
52. Khandaker, M. H., Mitchell, G., Xu, L., Andrews, J. D., Singh, R., Leung, H., et al. (1999). Metalloproteinases are involved in lipopolysaccharide- and tumor necrosis factor-alpha-mediated regulation of CXCR1 and CXCR2 chemokine receptor expression. Blood 93, 2173–2185.
53. Khandaker, M. H., Xu, L., Rahimpour, R., Mitchell, G., Devries, M. E., Pickering, J. G., et al. (1998). CXCR1 and CXCR2 are rapidly down-modulated by bacterial endotoxin through a unique agonist-independent, tyrosine kinase-dependent mechanism. J. Immunol.161, 1930–1938.
54. Khokha, R., Murthy, A., and Weiss, A. (2013). Metalloproteinases and their natural inhibitors in inflammation and immunity. Nat. Rev. Immunol. 13, 649–665. doi: 10.1038/nri3499
55. Kishimoto, T. K., Jutila, M. A., Berg, E. L., and Butcher, E. C. (1989). Neutrophil Mac-1 and MEL-14 adhesion proteins inversely regulated by chemotactic factors. Science 245, 1238–1241. doi: 10.1126/science.2551036
56. Kishimoto, T. K., Kahn, J., Migaki, G., Mainolfi, E., Shirley, F., Ingraham, R., et al. (1995). Regulation of L-selectin expression by membrane proximal proteolysis. Agents Actions Suppl. 47, 121–134. doi: 10.1007/978-3-0348-7343-7_11
57. Koenen, R. R., Pruessmeyer, J., Soehnlein, O., Fraemohs, L., Zernecke, A., Schwarz, N., et al. (2009). Regulated release and functional modulation of junctional adhesion molecule A by disintegrin metalloproteinases. Blood 113, 4799–4809. doi: 10.1182/blood-2008-04-152330
58. Kolaczkowska, E., and Kubes, P. (2013). Neutrophil recruitment and function in health and inflammation. Nat. Rev. Immunol. 13, 159–175. doi: 10.1038/nri3399
59. Kumar, G., Kumar, N., Taneja, A., Kaleekal, T., Tarima, S., Mcginley, E., et al. (2011). Nationwide trends of severe sepsis in the 21st century (2000–2007). Chest 140, 1223–1231. doi: 10.1378/chest.11-0352
60. Lajoie, L., Congy-Jolivet, N., Bolzec, A., Gouilleux-Gruart, V., Sicard, E., Sung, H. C., et al. (2014). ADAM17-mediated shedding of FcgammaRIIIA on human NK cells: identification of the cleavage site and relationship with activation. J. Immunol. 192, 741–751. doi: 10.4049/jimmunol.1301024
61. Lämmermann, T. (2016). In the eye of the neutrophil swarm-navigation signals that bring neutrophils together in inflamed and infected tissues. J. Leukoc. Biol. 100, 55–63. doi: 10.1189/jlb.1MR0915-403
62. Le Gall, S. M., Bobé, P., Reiss, K., Horiuchi, K., Niu, X. D., Lundell, D., et al. (2009). ADAMs 10 and 17 represent differentially regulated components of a general shedding machinery for membrane proteins such as transforming growth factor alpha, L-selectin, and tumor necrosis factor alpha. Mol. Biol. Cell 20, 1785–1794. doi: 10.1091/mbc.E08-11-1135
63. Le Gall, S. M., Maretzky, T., Issuree, P. D., Niu, X. D., Reiss, K., Saftig, P., et al. (2010). ADAM17 is regulated by a rapid and reversible mechanism that controls access to its catalytic site. J. Cell Sci. 123, 3913–3922. doi: 10.1242/jcs.069997
64. Lerman, Y. V., and Kim, M. (2015). Neutrophil migration under normal and sepsis conditions. Cardiovasc. Hematol. Disord. Drug Targets 15, 19–28. doi: 10.2174/1871529X15666150108113236
65. Li, N., Boyd, K., Dempsey, P. J., and Vignali, D. A. (2007). Non-cell autonomous expression of TNF-alpha-converting enzyme ADAM17 is required for normal lymphocyte development. J. Immunol. 178, 4214–4221. doi: 10.4049/jimmunol.178.7.4214
66. Li, X., Maretzky, T., Weskamp, G., Monette, S., Qing, X., Issuree, P. D., et al. (2015). iRhoms 1 and 2 are essential upstream regulators of ADAM17-dependent EGFR signaling. Proc. Natl. Acad. Sci. U.S.A. 112, 6080–6085. doi: 10.1073/pnas.1505649112
67. Li, Y., Brazzell, J., Herrera, A., and Walcheck, B. (2006). ADAM17 deficiency by mature neutrophils has differential effects on L-selectin shedding. Blood 108, 2275–2279. doi: 10.1182/blood-2006-02-005827
68. Liu, V., Escobar, G. J., Greene, J. D., Soule, J., Whippy, A., Angus, D. C., et al. (2014). Hospital deaths in patients with sepsis from 2 independent cohorts. JAMA 312, 90–92. doi: 10.1001/jama.2014.5804
69. Long, C., Hosseinkhani, M. R., Wang, Y., Sriramarao, P., and Walcheck, B. (2012). ADAM17 activation in circulating neutrophils following bacterial challenge impairs their recruitment. J. Leukoc. Biol. 92, 667–672. doi: 10.1189/jlb.0312112
70. Long, C., Wang, Y., Herrera, A. H., Horiuchi, K., and Walcheck, B. (2010). In vivo role of leukocyte ADAM17 in the inflammatory and host responses during E. coli-mediated peritonitis. J. Leukoc. Biol. 87, 1097–1101. doi: 10.1189/jlb.1109763
71. Lorenzen, I., Lokau, J., Korpys, Y., Oldefest, M., Flynn, C. M., Kunzel, U., et al. (2016). Control of ADAM17 activity by regulation of its cellular localisation. Sci. Rep. 6:35067. doi: 10.1038/srep35067
72. Lynam, E. B., Rogelj, S., Edwards, B. S., and Sklar, L. A. (1996). Enhanced aggregation of human neutrophils by MnCl2 or DTT differentiates the roles of L-selectin and beta 2-integrins. J. Leukoc. Biol. 60, 356–364.
73. Maretzky, T., Mcilwain, D. R., Issuree, P. D., Li, X., Malapeira, J., Amin, S., et al. (2013). iRhom2 controls the substrate selectivity of stimulated ADAM17-dependent ectodomain shedding. Proc. Natl. Acad. Sci. U.S.A. 110, 11433–11438. doi: 10.1073/pnas.1302553110
74. Maskos, K., Fernandez-Catalan, C., Huber, R., Bourenkov, G. P., Bartunik, H., Ellestad, G. A., et al. (1998). Crystal structure of the catalytic domain of human tumor necrosis factor-alpha-converting enzyme. Proc. Natl. Acad. Sci. U.S.A. 95, 3408–3412. doi: 10.1073/pnas.95.7.3408
75. Matthews, A. L., Noy, P. J., Reyat, J. S., and Tomlinson, M. G. (2016). Regulation of A disintegrin and metalloproteinase (ADAM) family sheddases ADAM10 and ADAM17: the emerging role of tetraspanins and rhomboids. Platelets. doi: 10.1080/09537104.2016.1184751. [Epub ahead of print].
76. Mayadas, T. N., Cullere, X., and Lowell, C. A. (2014). The multifaceted functions of neutrophils. Annu. Rev. Pathol. 9, 181–218. doi: 10.1146/annurev-pathol-020712-164023
77. Mcilwain, D. R., Lang, P. A., Maretzky, T., Hamada, K., Ohishi, K., Maney, S. K., et al. (2012). iRhom2 regulation of TACE controls TNF-mediated protection against Listeria and responses to LPS. Science 335, 229–232. doi: 10.1126/science.1214448
78. Mezyk, R., Bzowska, M., and Bereta, J. (2003). Structure and functions of tumor necrosis factor-alpha converting enzyme. Acta Biochim. Pol. 50, 625–645.
79. Mishra, H. K., Johnson, T. J., Seelig, D. M., and Walcheck, B. (2016). Targeting ADAM17 in leukocytes increases neutrophil recruitment and reduces bacterial spread during polymicrobial sepsis. J. Leukoc. Biol. 100, 999–1004. doi: 10.1189/jlb.3VMAB1115-496RR
80. Mishra, H. K., Long, C., Bahaie, N. S., and Walcheck, B. (2015). Regulation of CXCR2 expression and function by a disintegrin and metalloprotease-17 (ADAM17). J. Leukoc. Biol. 97, 447–454. doi: 10.1189/jlb.3HI0714-340R
81. Moss, M. L., Jin, S. L., Milla, M. E., Bickett, D. M., Burkhart, W., Carter, H. L., et al. (1997). Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature 385, 733–736. doi: 10.1038/385733a0
82. Muller Kobold, A. C., Zijlstra, J. G., Koene, H. R., De Haas, M., Kallenberg, C. G., and Tervaert, J. W. (1998). Levels of soluble Fc gammaRIII correlate with disease severity in sepsis. Clin. Exp. Immunol. 114, 220–227. doi: 10.1046/j.1365-2249.1998.00727.x
83. O'neill, S., Robinson, A., Deering, A., Ryan, M., Fitzgerald, D. J., and Moran, N. (2000). The platelet integrin alpha IIbbeta 3 has an endogenous thiol isomerase activity. J. Biol. Chem. 275, 36984–36990. doi: 10.1074/jbc.M003279200
84. Peschon, J. J., Slack, J. L., Reddy, P., Stocking, K. L., Sunnarborg, S. W., Lee, D. C., et al. (1998). An essential role for ectodomain shedding in mammalian development. Science 282, 1281–1284. doi: 10.1126/science.282.5392.1281
85. Reddy, P., Slack, J. L., Davis, R., Cerretti, D. P., Kozlosky, C. J., Blanton, R. A., et al. (2000). Functional analysis of the domain structure of tumor necrosis factor-alpha converting enzyme. J. Biol. Chem. 275, 14608–14614. doi: 10.1074/jbc.275.19.14608
86. Rizoli, S. B., Rotstein, O. D., and Kapus, A. (1999). Cell volume-dependent regulation of L-selectin shedding in neutrophils. A role for p38 mitogen-activated protein kinase. J. Biol. Chem. 274, 22072–22080. doi: 10.1074/jbc.274.31.22072
87. Rosendahl, M. S., Ko, S. C., Long, D. L., Brewer, M. T., Rosenzweig, B., Hedl, E., et al. (1997). Identification and characterization of a pro-tumor necrosis factor-α-processing enzyme from the ADAM family of zinc metalloproteases. J. Biol. Chem. 272, 24588–24593. doi: 10.1074/jbc.272.39.24588
88. Sadik, C. D., Kim, N. D., and Luster, A. D. (2011). Neutrophils cascading their way to inflammation. Trends Immunol. 32, 452–460. doi: 10.1016/j.it.2011.06.008
89. Schaff, U., Mattila, P. E., Simon, S. I., and Walcheck, B. (2008). Neutrophil adhesion to E-selectin under shear promotes the redistribution and co-clustering of ADAM17 and its proteolytic substrate L-selectin. J. Leukoc. Biol. 83, 99–105. doi: 10.1189/jlb.0507304
90. Scheller, J., Chalaris, A., Garbers, C., and Rose-John, S. (2011). ADAM17: a molecular switch to control inflammation and tissue regeneration. Trends Immunol. 32, 380–387. doi: 10.1016/j.it.2011.05.005
91. Schlöndorff, J., Becherer, J. D., and Blobel, C. P. (2000). Intracellular maturation and localization of the tumour necrosis factor alpha convertase (TACE). Biochem. J. 347 (Pt 1), 131–138. doi: 10.1042/bj3470131
92. Schulte, W., Bernhagen, J., and Bucala, R. (2013). Cytokines in sepsis: potent immunoregulators and potential therapeutic targets–an updated view. Mediators Inflamm. 2013:165974. doi: 10.1155/2013/165974
93. Schwarz, J., Broder, C., Helmstetter, A., Schmidt, S., Yan, I., Müller, M., et al. (2013). Short-term TNFα shedding is independent of cytoplasmic phosphorylation or furin cleavage of ADAM17. Biochim. Biophys. Acta 1833, 3355–3367. doi: 10.1016/j.bbamcr.2013.10.005
94. Schwarz, J., Schmidt, S., Will, O., Koudelka, T., Köhler, K., Boss, M., et al. (2014). Polo-like kinase 2, a novel ADAM17 signaling component, regulates tumor necrosis factor alpha ectodomain shedding. J. Biol. Chem. 289, 3080–3093. doi: 10.1074/jbc.M113.536847
95. Shao, Y., He, J., Chen, F., Cai, Y., Zhao, J., Lin, Y., et al. (2016). Association study between promoter polymorphisms of ADAM17 and progression of sepsis. Cell. Physiol. Biochem. 39, 1247–1261. doi: 10.1159/000447830
96. Singer, M., Deutschman, C. S., Seymour, C. W., Shankar-Hari, M., Annane, D., Bauer, M., et al. (2016). The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315, 801–810. doi: 10.1001/jama.2016.0287
97. Smookler, D. S., Mohammed, F. F., Kassiri, Z., Duncan, G. S., Mak, T. W., and Khokha, R. (2006). Tissue inhibitor of metalloproteinase 3 regulates TNF-dependent systemic inflammation. J. Immunol. 176, 721–725. doi: 10.4049/jimmunol.176.2.721
98. Sommer, A., Kordowski, F., Büch, J., Maretzky, T., Evers, A., Andrä, J., et al. (2016). Phosphatidylserine exposure is required for ADAM17 sheddase function. Nat. Commun. 7:11523. doi: 10.1038/ncomms11523
99. Sônego, F., Alves-Filho, J. C., and Cunha, F. Q. (2014). Targeting neutrophils in sepsis. Expert Rev. Clin. Immunol. 10, 1019–1028. doi: 10.1586/1744666X.2014.922876
100. Soond, S. M., Everson, B., Riches, D. W., and Murphy, G. (2005). ERK-mediated phosphorylation of Thr735 in TNFα-converting enzyme and its potential role in TACE protein trafficking. J. Cell Sci. 118, 2371–2380. doi: 10.1242/jcs.02357
101. Sperandio, M., Smith, M. L., Forlow, S. B., Olson, T. S., Xia, L., Mcever, R. P., et al. (2003). P-selectin glycoprotein ligand-1 mediates L-selectin-dependent leukocyte rolling in venules. J. Exp. Med. 197, 1355–1363. doi: 10.1084/jem.20021854
102. St. Hill, C. A., Alexander, S. R., and Walcheck, B. (2003). Indirect capture augments leukocyte accumulation on P-selectin in flowing whole blood. J. Leukoc. Biol. 73, 464–471. doi: 10.1189/jlb.1002491
103. Stadtmann, A., and Zarbock, A. (2012). CXCR2: From Bench to Bedside. Front. Immunol. 3:263. doi: 10.3389/fimmu.2012.00263
104. Stawikowska, R., Cudic, M., Giulianotti, M., Houghten, R. A., Fields, G. B., and Minond, D. (2013). Activity of ADAM17 (a disintegrin and metalloprotease 17) is regulated by its noncatalytic domains and secondary structure of its substrates. J. Biol. Chem. 288, 22871–22879. doi: 10.1074/jbc.M113. 462267
105. Stillie, R., Farooq, S. M., Gordon, J. R., and Stadnyk, A. W. (2009). The functional significance behind expressing two IL-8 receptor types on PMN. J. Leukoc. Biol. 86, 529–543. doi: 10.1189/jlb.0208125
106. Takeda, S. (2016). ADAM and ADAMTS family proteins and snake venom metalloproteinases: a structural overview. Toxins 8:155. doi: 10.3390/toxins8050155
107. Tang, J., Zarbock, A., Gomez, I., Wilson, C. L., Lefort, C. T., Stadtmann, A., et al. (2011). Adam17-dependent shedding limits early neutrophil influx but does not alter early monocyte recruitment to inflammatory sites. Blood 118, 786–794. doi: 10.1182/blood-2010-11-321406
108. Thorp, E., Vaisar, T., Subramanian, M., Mautner, L., Blobel, C., and Tabas, I. (2011). Shedding of the Mer tyrosine kinase receptor is mediated by ADAM17 protein through a pathway involving reactive oxygen species, protein kinase Cdelta, and p38 mitogen-activated protein kinase (MAPK). J. Biol. Chem. 286, 33335–33344. doi: 10.1074/jbc.M111.263020
109. Tsuboi, N., Asano, K., Lauterbach, M., and Mayadas, T. N. (2008). Human neutrophil Fcgamma receptors initiate and play specialized nonredundantroles in antibody-mediated inflammatory diseases. Immunity 28, 833–846. doi: 10.1016/j.immuni.2008.04.013
110. Tsukerman, P., Eisenstein, E. M., Chavkin, M., Schmiedel, D., Wong, E., Werner, M., et al. (2015). Cytokine secretion and NK cell activity in human ADAM17 deficiency. Oncotarget 6, 44151–44160. doi: 10.18632/oncotarget.6629
111. Tucher, J., Linke, D., Koudelka, T., Cassidy, L., Tredup, C., Wichert, R., et al. (2014). LC-MS based cleavage site profiling of the proteases ADAM10 and ADAM17 using proteome-derived peptide libraries. J. Proteome Res. 13, 2205–2214. doi: 10.1021/pr401135u
112. Walcheck, B., Herrera, A. H., St. Hill, C., Mattila, P. E., Whitney, A. R., and Deleo, F. R. (2006). ADAM17 activity during human neutrophil activation and apoptosis. Eur. J. Immunol. 36, 968–976. doi: 10.1002/eji.200535257
113. Walcheck, B., Kahn, J., Fisher, J. M., Wang, B. B., Fisk, R. S., Payan, D. G., et al. (1996a). Neutrophil rolling altered by inhibition of L-selectin shedding in vitro. Nature 380, 720–723. doi: 10.1038/380720a0
114. Walcheck, B., Moore, K. L., Mcever, R. P., and Kishimoto, T. K. (1996b). Neutrophil-neutrophil interactions under hydrodynamic shear stress involve L-selectin and PSGL-1. A mechanism that amplifies initial leukocyte accumulation of P-selectin in vitro. J. Clin. Invest. 98, 1081–1087. doi: 10.1172/JCI118888
115. Walsh, G.M., Sheehan, D., Kinsella, A., Moran, N., and O'neill, S. (2004). Redox modulation of integrin [correction of integin] alpha IIb beta 3 involves a novel allosteric regulation of its thiol isomerase activity. Biochemistry 43, 473–480. doi: 10.1021/bi0354536
116. Wang, Y., Herrera, A. H., Li, Y., Belani, K. K., and Walcheck, B. (2009). Regulation of mature ADAM17 by redox agents for L-selectin shedding. J. Immunol. 182, 2449–2457. doi: 10.4049/jimmunol.0802770
117. Wang, Y., Robertson, J. D., and Walcheck, B. (2011). Different signaling pathways stimulate a disintegrin and metalloprotease-17 (ADAM17) in neutrophils during apoptosis and activation. J. Biol. Chem. 286, 38980–38988. doi: 10.1074/jbc.M111.277087
118. Wang, Y., Wu, J., Newton, R., Bahaie, N. S., Long, C., and Walcheck, B. (2013). ADAM17 cleaves CD16b (FcgammaRIIIb) in human neutrophils. Biochim. Biophys. Acta 1833, 680–685. doi: 10.1016/j.bbamcr.2012. 11.027
119. Wang, Y., Zhang, A. C., Ni, Z., Herrera, A., and Walcheck, B. (2010). ADAM17 activity and other mechanisms of soluble L-selectin production during death receptor-induced leukocyte apoptosis. J. Immunol. 184, 4447–4454. doi: 10.4049/jimmunol.0902925
120. Weber, S., and Saftig, P. (2012). Ectodomain shedding and ADAMs in development. Development 139, 3693–3709. doi: 10.1242/dev.076398
121. Weskamp, G., Mendelson, K., Swendeman, S., Le Gall, S., Ma, Y., Lyman, S., et al. (2010). Pathological neovascularization is reduced by inactivation of ADAM17 in endothelial cells but not in pericytes. Circ. Res. 106, 932–940. doi: 10.1161/CIRCRESAHA.109.207415
122. Willems, S. H., Tape, C. J., Stanley, P. L., Taylor, N. A., Mills, I. G., Neal, D. E., et al. (2010). Thiol isomerases negatively regulate the cellular shedding activity of ADAM17. Biochem. J. 428, 439–450. doi: 10.1042/BJ201 00179
123. Wisniewska, M., Goettig, P., Maskos, K., Belouski, E., Winters, D., Hecht, R., et al. (2008). Structural determinants of the ADAM inhibition by TIMP-3: crystal structure of the TACE-N-TIMP-3 complex. J. Mol. Biol. 381, 1307–1319. doi: 10.1016/j.jmb.2008. 06.088
124. Xu, P., Liu, J., Sakaki-Yumoto, M., and Derynck, R. (2012). TACE activation by MAPK-mediated regulation of cell surface dimerization and TIMP3 association. Sci. Signal. 5:ra34. doi: 10.1126/scisignal.2002689
125. Xu, X. R., Carrim, N., Neves, M. A., Mckeown, T., Stratton, T. W., Coelho, R. M., et al. (2016). Platelets and platelet adhesion molecules: novel mechanisms of thrombosis and anti-thrombotic therapies. Thromb. J. 14:29. doi: 10.1186/s12959-016-0100-6
126. Zhao, L., Shey, M., Farnsworth, M., and Dailey, M. O. (2001). Regulation of membrane metalloproteolytic cleavage of L-selectin (CD62l) by the epidermal growth factor domain. J. Biol. Chem. 276, 30631–30640. doi: 10.1074/jbc.M103748200
127. Zhang, F., Liu, A. L., Gao, S., Ma, S., and Guo, S. B. (2016). Neutrophil dysfunction in sepsis. Chinese Med. J. 129:2741. doi: 10.4103/0366-6999.193447
128. Zonneveld, R., Martinelli, R., Shapiro, N. I., Kuijpers, T. W., Plotz, F. B., and Carman, C. V. (2014). Soluble adhesion molecules as markers for sepsis and the potential pathophysiological discrepancy in neonates, children and adults. Crit. Care 18:204. doi: 10.1186/cc13733